Edition:
United States

Xenon Pharmaceuticals Inc (XENE.OQ)

XENE.OQ on NASDAQ Stock Exchange Global Market

3.75USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$3.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,401
52-wk High
$9.90
52-wk Low
$2.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.26 -0.430
Jun '17 0.01 -0.410
Mar '17 0.02 -0.419
FY 2016 Dec '16 0.38 -0.335
Sep '16 0.41 -0.505
Jun '16 0.41 -0.418
Mar '16 0.60 -0.227
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 3 5.17 13.50 0.00 28.83
Earnings (per share)
Year Ending Dec-18 3 -1.67 -1.07 -2.00 -0.44
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 192.73 34.59
P/E High - Last 5 Yrs. 21.51 285.47 45.93
P/E Low - Last 5 Yrs. 21.51 93.40 24.19
Beta -- 0.81 0.81
Price to Sales (TTM) 100.45 137.31 8.08
Price to Book (MRQ) 1.56 20.28 5.24
Price to Tangible Book (MRQ) 1.56 27.91 6.43
Price to Cash Flow (TTM) -- 126.48 25.98
% Owned Institutions 60.47 11.77 2.27

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.87 5.21
Payout Ratio(TTM) -- 8.18 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -36.08 65.12 9.76
Sales (TTM) vs TTM 1 Yr. Ago -85.58 62.55 7.61
Sales - 5 Yr. Growth Rate -23.58 33.48 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 14.86 -97.40 18.78
EPS (TTM) vs TTM 1 Yr. Ago -12.02 -- --
EPS - 5 Yr. Growth Rate -- 46.98 11.55
Capital Spending - 5 Yr. Growth Rate -0.77 43.68 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 14.71 6.12 3.39
LT Debt to Equity (MRQ) 0.00 16.26 12.18
Total Debt to Equity (MRQ) 0.00 18.35 15.60
Interest Coverage (TTM) -- -160.93 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.39 54.74
Gross Margin - 5 Yr. Avg. -- 55.21 52.50
EBITD Margin (TTM) -4,369.30 -- --
EBITD - 5 Yr. Avg -14.16 -233.45 14.67
Operating Margin (TTM) -4,468.85 -490.18 4.40
Operating Margin - 5 Yr. Avg. -18.89 -250.27 9.99
Pre-Tax Margin (TTM) -4,268.70 -465.60 5.14
Pre-Tax Margin - 5 Yr. Avg. -20.59 -256.86 10.24
Net Profit Margin (TTM) -4,268.70 -447.98 1.86
Net Profit Margin - 5 Yr. Avg. -20.59 -260.25 6.55
Effective Tax Rate (TTM) -- 0.27 21.87
Effective Tax Rate - 5 Yr. Avg. -- 17.76 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 7,625 23,887,942 823,803,020
Net Income/Employee (TTM) -325,489 -537,326 96,327,335
Receivable Turnover (TTM) 1.85 14.02 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) 0.01 0.39 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.85 -1.02 10.76
Return on Assets - 5 Yr. Avg. -- -0.09 12.05
Return on Investment (TTM) -50.83 -0.67 13.67
Return on Investment - 5 Yr. Avg. -- 2.39 15.78
Return on Equity (TTM) -50.87 -3.38 15.40
Return on Equity - 5 Yr. Avg. -- -1.61 17.04
  1 Year 3 Year 5 Year
Sales % -88.43 -59.61 -23.58
EPS (TTM) % -34.58 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Xenon Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 60.47%
# of Holders: 38
Total Shares Held: 10,883,815
3 Mo. Net Change: -547,105
# New Positions: 8
# Closed Positions: 5
# Increased Positions: 18
# Reduced Positions: 7
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.